Charlene Mantia has Medical Oncology as her primary medical specialty. Their primary office is: 450 Brookline Ave in Boston, Massachusetts.
They're a part of the: Dana-farber Cancer Institute, Inc. medical group which has around 542 members. You can call their office at - to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Albany Medical College Of Union University and graduated in 2014 (around 10 years of experience). They are listed as doing telehealth appointments.
Charlene Mantia
Dana-farber Cancer Institute, Inc.
450 Brookline Ave
Boston, Massachusetts 02215
-
Enter a starting address:
Additional Medical Specialties Include:
HEMATOLOGY
Medical School: Albany Medical College Of Union University
Graduation Year: 2014
The Primary Medical Specialty for Charlene Mantia is listed as: Medical Oncology
Approximate Years of Experience: 10
PAC (PECOS ID)#: 2961711494
NPI #: 1831503218
NPI Created On: 06/13/2014
NPI Last Updated Listed as: 06/11/2020
Primary Taxonomy Code: 207RX0202X
License Number:
282567
Listed Gender: Female
Services and Procedures include:
450 Brookline Ave
Boston, MA
Dana-farber Cancer Institute, Inc.
450 Brookline Ave
Boston, MA
Dana-farber Cancer Institute, Inc.
450 Brookline Ave
Boston, MA
Dana-farber Cancer Institute, Inc.
450 Brookline Ave
Boston, MA
Dana-farber Cancer Institute, Inc.
75 Francis St
Boston, MA
Dana-farber Cancer Institute, Inc.
450 Brookline Ave
Boston, MA
Dana-farber Cancer Institute, Inc.
20 Prospect St
Milford Ma 01757-3042
Dana-farber Cancer Institute, Inc.
Medical Oncology
450 Brookline Ave
Boston Ma 02215-5418
Dana-farber Cancer Institute, Inc.
Medical Oncology
75 Francis St
Boston Ma 02115-6110
Dana-farber Cancer Institute, Inc.
Internal Medicine
450 Brookline Ave
Boston Ma 02215-5418
Dana-farber Cancer Institute, Inc.
Internal Medicine
22 Patriot Pl
Foxborough Ma 02035-1375
Dana-farber Cancer Institute, Inc.
Medical Oncology
75 Francis St
Boston Ma 02115-6110
Dana-farber Cancer Institute, Inc.
Medical Oncology
View all 542 members of Dana-farber Cancer Institute, Inc. medical group